Brexit: Health Secretary provides update

Brexit: Health Secretary provides update

April 4, 2019

The Secretary of State for Health and Social Care has written to frontline health professionals to provide an update on the Government’s Brexit preparations.

Mr Hancock’s letter outlines the most recent information on key healthcare issues relating to the UK’s exit from the EU, including medicines supply and the effect on healthcare professionals from the EU.

You can view the letter here, but we have summarised the information below.

Medicines and prescribing in the event of a no-deal

Government advice has remained consistent. The letter reiterates that whilst pharmaceutical companies have been asked to stockpile medicines, local stockpiling at pharmacy and patient level is unnecessary.

The Department of Health and Social Care (DHSC) continues to work with industry stakeholders and is confident that medicines will continue to reach patients in the event of a no-deal Brexit.

Continued recognition of EU professional qualifications in the UK

DHSC has confirmed that EU staff who are currently practising in the UK can continue to do so, and that professionals qualified in the European Economic Area (EEA) and Switzerland can continue to apply for registration after exit day, even if the UK leaves without a deal.

European qualifications will also continue to be recognised by all professional health regulators, including the General Pharmaceutical Council (GPhC).

Further information is available here.

EU health and social care staff who wish to remain in the UK after it leaves the EU

EU citizens working in the NHS and in social care are encouraged to apply to the Government’s EU Settlement Scheme.

View full details of the EU Settlement Scheme.


For the latest EU exit updates and guidance, please visit our Brexit hub.

Posted in: , , ,

More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...